Brief: Glaxosmithkline Pharma Sept-Quarter Consol Profit Falls
11/11/2022 11:49
Nov 11 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd GLAX.NS :
* SEPT-QUARTER CONSOL PROFIT 1.93 BILLION RUPEES VERSUS 2.04 BILLION RUPEES
* SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 9.17 BILLION RUPEES VERSUS
9.34
BILLION RUPEES
Source text for Eikon: ID:
Further company coverage: GLAX.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees